Citadel Advisors
BCPC

Citadel Advisors’s Balchem Corp BCPC Stock Holding History

Citadel Advisors’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.51M Buy
20,688
+10,512
+103% +$1.79M ﹤0.01% 4954
2025
Q4 		$1.56M Sell
10,176
-40,256
-80% -$6.14M ﹤0.01% 6420
2025
Q3 		$7.57M Sell
50,432
-31,150
-38% -$4.91M ﹤0.01% 3660
2025
Q2 		$13M Buy
81,582
+17,760
+28% +$2.88M ﹤0.01% 2684
2025
Q1 		$10.6M Buy
63,822
+19,172
+43% +$3.14M ﹤0.01% 2779
2024
Q4 		$7.28M Buy
44,650
+43,258
+3,108% +$7.51M ﹤0.01% 3387
2024
Q3 		$245K Sell
1,392
-13,123
-90% -$2.23M ﹤0.01% 9725
2024
Q2 		$2.23M Buy
14,515
+13,560
+1,420% +$2.04M ﹤0.01% 5108
2024
Q1 		$148K Buy
+955
New +$142K ﹤0.01% 10786
2023
Q4 		– Sell
-13,192
Closed -$1.69M – 15435
2023
Q3 		$1.64M Buy
13,192
+3,468
+36% +$461K ﹤0.01% 5578
2023
Q2 		$1.31M Sell
9,724
-8,472
-47% -$1.09M ﹤0.01% 5917
2023
Q1 		$2.3M Buy
18,196
+15,136
+495% +$1.96M ﹤0.01% 5099
2022
Q4 		$374K Sell
3,060
-584
-16% -$77.1K ﹤0.01% 8855
2022
Q3 		$443K Sell
3,644
-18,468
-84% -$2.41M ﹤0.01% 8729
2022
Q2 		$2.87M Buy
+22,112
New +$2.77M ﹤0.01% 4839
2022
Q1 		– Sell
-12,900
Closed -$1.85M – 14774
2021
Q4 		$2.17M Buy
12,900
+10,692
+484% +$1.72M ﹤0.01% 6041
2021
Q3 		$320K Sell
2,208
-20,236
-90% -$2.74M ﹤0.01% 10926
2021
Q2 		$2.95M Buy
22,444
+15,984
+247% +$2.06M ﹤0.01% 5649
2021
Q1 		$810K Sell
6,460
-30,572
-83% -$3.71M ﹤0.01% 8619
2020
Q4 		$4.27M Sell
37,032
-3,963
-10% -$418K ﹤0.01% 3943
2020
Q3 		$4M Sell
40,995
-46,460
-53% -$4.55M ﹤0.01% 3485
2020
Q2 		$8.3M Buy
87,455
+68,326
+357% +$6.39M ﹤0.01% 2447
2020
Q1 		$1.89M Buy
19,129
+11,924
+165% +$1.22M ﹤0.01% 4236
2019
Q4 		$732K Buy
+7,205
New +$727K ﹤0.01% 6166
2019
Q1 		– Sell
-19,053
Closed -$1.49M – 9988
2018
Q4 		$1.49M Buy
19,053
+16,851
+765% +$1.52M ﹤0.01% 4639
2018
Q3 		$247K Buy
+2,202
New +$231K ﹤0.01% 7894
2018
Q1 		– Sell
-12,477
Closed -$1M – 8893
2017
Q4 		$1M Buy
12,477
+9,872
+379% +$822K ﹤0.01% 4642
2017
Q3 		$212K Buy
+2,605
New +$200K ﹤0.01% 6607
2017
Q2 		– Sell
-8,157
Closed -$672K – 8194
2017
Q1 		$672K Sell
8,157
-4,587
-36% -$386K ﹤0.01% 4563
2016
Q4 		$1.07M Buy
12,744
+5,382
+73% +$425K ﹤0.01% 3765
2016
Q3 		$571K Buy
+7,362
New +$489K ﹤0.01% 4649
2015
Q3 		– Sell
-5,091
Closed -$284K – 9296
2015
Q2 		$284K Buy
+5,091
New +$293K ﹤0.01% 5820
2014
Q4 		– Sell
-8,293
Closed -$469K – 8774
2014
Q3 		$469K Sell
8,293
-20,145
-71% -$1.07M ﹤0.01% 4707
2014
Q2 		$1.52M Buy
28,438
+14,120
+99% +$810K ﹤0.01% 3005
2014
Q1 		$746K Buy
14,318
+10,226
+250% +$549K ﹤0.01% 3806
2013
Q4 		$240K Buy
+4,092
New +$231K ﹤0.01% 4836

Other funds holding BCPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors's BCPC Position: Q1 2026 in Review

Citadel Advisors increased its Balchem Corp (BCPC) stake by 103% in Q1 2026, buying an estimated $1.79M and bringing the position to 20,688 shares worth $3.51M. The position accounts for ﹤0.01% of the portfolio, ranked #4954.

Citadel Advisors first reported a position in BCPC in Q4 2013 and has held it in 36 quarters since. The position peaked at $13M in Q2 2025. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • Citadel Advisors held 20,688 shares of Balchem Corp worth $3.51M as of Q1 2026.
  • Citadel Advisors bought 10,512 Balchem Corp shares in Q1 2026, an estimated $1.79M.
  • Balchem Corp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4954 holding.
  • Citadel Advisors first reported a position in Balchem Corp in Q4 2013 and has held it in 36 quarters since.
  • Citadel Advisors's Balchem Corp position peaked at $13M in Q2 2025.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.